Cargando…

In silico screening of potential compounds from begonia genus as 3CL protease (3Cl pro) SARS-CoV-2 inhibitors

BACKGROUND: The emergence of Coronavirus disease (COVID-19) has been declared a pandemic and made a medical emergency worldwide. Various attempts have been made, including optimizing effective treatments against the disease or developing a vaccine. Since the SARS-CoV-2 protease crystal structure has...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maulana, Saipul, Wahyuni, Tutik Sri, Widiyanti, Prihartini, Zubair, Muhammad Sulaiman
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	PAGEPress Publications, Pavia, Italy 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10365649/ https://www.ncbi.nlm.nih.gov/pubmed/37492544 http://dx.doi.org/10.4081/jphia.2023.2508

Ejemplares similares

Antiviral phytocompounds “ellagic acid” and “(+)-sesamin” of Bridelia retusa identified as potential inhibitors of SARS-CoV-2 3CL pro using extensive molecular docking, molecular dynamics simulation studies, binding free energy calculations, and bioactivity prediction
por: Umar, Abd. Kakhar, et al.
Publicado: (2022)

In-silico approaches for identification of compounds inhibiting SARS-CoV-2 3CL protease
por: Zeyaullah, Md., et al.
Publicado: (2023)

Assessment of activity of chalcone compounds as inhibitors of 3-chymotrypsin like protease (3CL(Pro)) of SARS-CoV-2: in silico study
por: Mathpal, Shalini, et al.
Publicado: (2022)

GC-MS, LC-MS/MS, Docking and Molecular Dynamics Approaches to Identify Potential SARS-CoV-2 3-Chymotrypsin-Like Protease Inhibitors from Zingiber officinale Roscoe
por: Zubair, Muhammad Sulaiman, et al.
Publicado: (2021)

In silico analysis of echinocandins binding to the main proteases of coronaviruses PEDV (3CL(pro)) and SARS-CoV-2 (M(pro))
por: Vergoten, Gérard, et al.
Publicado: (2021)

IN SILICO SCREENING AND BIOLOGICAL EVALUATION OF THE COMPOUNDS OF Justicia gendarussa LEAVES EXTRACT AS INTERFERON GAMMA INDUCER: A STUDY OF ANTI HUMAN IMMUNODEFICIENCY VIRUS (HIV) DEVELOPMENT
por: Sinansari, Restry, et al.
Publicado: (2018)

In silico and in vitro analysis of small molecules and natural compounds targeting the 3CL protease of feline infectious peritonitis virus
por: Theerawatanasirikul, Sirin, et al.
Publicado: (2020)

QM/QM studies for Michael reaction in coronavirus main protease (3CL(Pro))
por: Taranto, Alex G., et al.
Publicado: (2008)

The development of Coronavirus 3C-Like protease (3CL(pro)) inhibitors from 2010 to 2020
por: Liu, Yuzhi, et al.
Publicado: (2020)

Inhibition of the SARS-CoV-2 3CL(pro) main protease by plant polyphenols
por: Bahun, Miha, et al.
Publicado: (2022)

Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors
por: Iketani, Sho, et al.
Publicado: (2020)

Evaluation of metal‐conjugated compounds as inhibitors of 3CL protease of SARS‐CoV
por: Hsu, John T.-A., et al.
Publicado: (2004)

Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors
por: Iketani, Sho, et al.
Publicado: (2021)

Plant Products as Inhibitors of Coronavirus 3CL Protease
por: Mandal, Anirban, et al.
Publicado: (2021)

Antcin-B, a phytosterol-like compound from Taiwanofungus camphoratus inhibits SARS-CoV-2 3-chymotrypsin-like protease (3CL(Pro)) activity in silico and in vitro
por: Dakpa, Gyaltsen, et al.
Publicado: (2023)

Development of Broad‐Spectrum Halomethyl Ketone Inhibitors Against Coronavirus Main Protease 3CL(pro)
por: Bacha, Usman, et al.
Publicado: (2008)

Repurposing of HIV/HCV protease inhibitors against SARS-CoV-2 3CL(pro)
por: Ma, Ling, et al.
Publicado: (2022)

Hybrid Approach to Identifying Druglikeness Leading Compounds against COVID-19 3CL Protease
por: Aqeel, Imra, et al.
Publicado: (2022)

Molecular Docking and Molecular Dynamics Studies of Antidiabetic Phenolic Compound Isolated from Leaf Extract of Englerophytum magalismontanum (Sond.) T.D.Penn.
por: Olaokun, Oyinlola Oluwunmi, et al.
Publicado: (2022)

Inhibition of SARS-CoV 3CL protease by flavonoids
por: Jo, Seri, et al.
Publicado: (2019)

In silico screening-based discovery of novel covalent inhibitors of the SARS-CoV-2 3CL protease
por: Xiong, Muya, et al.
Publicado: (2022)

Virtual high throughput screening: Potential inhibitors for SARS-CoV-2 PL(PRO) and 3CL(PRO) proteases
por: Jade, Dhananjay, et al.
Publicado: (2021)

Prioritisation of Compounds for 3CL(pro) Inhibitor Development on SARS-CoV-2 Variants
por: Jukič, Marko, et al.
Publicado: (2021)

Binding interaction of SARS coronavirus 3CL(pro) protease with vacuolar‐H(+) ATPase G1 subunit
por: Lin, Cheng-Wen, et al.
Publicado: (2005)

Inhibition of SARS-CoV-2 main protease 3CL(pro) by means of α-ketoamide and pyridone-containing pharmaceuticals using in silico molecular docking
por: Elzupir, Amin O.
Publicado: (2020)

Author Correction: Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors
por: Iketani, Sho, et al.
Publicado: (2021)

Chetomin, a SARS-CoV-2 3C-like Protease (3CL(pro)) Inhibitor: In Silico Screening, Enzyme Docking, Molecular Dynamics and Pharmacokinetics Analysis
por: Ibrahim, Mahmoud A. A., et al.
Publicado: (2023)

Targeting novel structural and functional features of coronavirus protease nsp5 (3CL(pro), M(pro)) in the age of COVID-19
por: Roe, Molly K., et al.
Publicado: (2021)

Mechanism of the Maturation Process of SARS-CoV 3CL Protease
por: Hsu, Min-Feng, et al.
Publicado: (2005)

Hypericin Inhibit Alpha-Coronavirus Replication by Targeting 3CL Protease
por: Zhang, Yue, et al.
Publicado: (2021)

Eupatin, a Flavonoid, Inhibits Coronavirus 3CL Protease and Replication
por: Park, Yea-In, et al.
Publicado: (2023)

Docking Study on Anti-HIV-1 Activity of Secondary Metabolites from Zingiberaceae Plants
por: Zubair, Muhammad Sulaiman, et al.
Publicado: (2020)

Discovery of Novel Chinese Medicine Compounds Targeting 3CL Protease by Virtual Screening and Molecular Dynamics Simulation
por: Cheng, Jin, et al.
Publicado: (2023)

Exploration of chalcones as 3-chymotrypsin-like protease (3CL(pro)) inhibitors of SARS-CoV-2 using computational approaches
por: Lam, Thua-Phong, et al.
Publicado: (2022)

In silico prediction of the inhibition of new molecules on SARS-CoV-2 3CL protease by using QSAR: PSOSVR approach
por: Madani, Achouak, et al.
Publicado: (2023)

Profiling of Substrate Specificity of SARS-CoV 3CL(pro)
por: Chuck, Chi-Pang, et al.
Publicado: (2010)

Engineering a novel endopeptidase based on SARS 3CL(pro)
por: Kuo, Chih-Jung, et al.
Publicado: (2009)

COMBINATION OF SALTS AND PROTEINS : III. THE COMBINATION OF CuCl(2), MgCl(2), CaCl(2), AlCl(3), LaCl(3), KCl, AgNO(3)AND Na(2)SO(4)WITH GELATIN.
por: Northrop, John H., et al.
Publicado: (1928)

Molecular cloning, expression, purification and crystallographic analysis of PRRSV 3CL protease
por: Tian, Xinsheng, et al.
Publicado: (2007)

Inhibition of the 3CL Protease and SARS-CoV-2 Replication by Dalcetrapib
por: Niesor, Eric J, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ormb3at6fggn5053t1hdhjd4t2